A Mycobacterium tuberculosis rare variable antigen vaccine reduces lung pathology in hypersusceptible SP140−/− mice
Mycobacterium tuberculosis is the leading cause of death globally due to a single infectious agent. Currently, no licensed vaccine protects against pulmonary tuberculosis, the primary adult disease caused by Mtb infection. CD4 T cells are essential in protection against Mtb infection and inducing a...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2026-07-01
|
| Series: | Frontiers in Tuberculosis |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/ftubr.2026.1814646/full |
| Tags: |
No Tags, Be the first to tag this record!
|
